Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.
Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, a minor update with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check15 days agoChange DetectedAdded related topics Cystic fibrosis and MedlinePlus Genetics, and updated the revision from v3.2.0 to v3.3.1.SummaryDifference0.2%
- Check23 days agoChange DetectedRemoved the temporary government funding lapse notice from the page, including references to cc.nih.gov and opm.gov. The page now presents study details without that operational alert.SummaryDifference0.4%
- Check37 days agoChange DetectedRemoved Cystic fibrosis and MedlinePlus Genetics from the related topics section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check44 days agoChange DetectedAdded related topics: Cystic fibrosis and MedlinePlus Genetics to the page.SummaryDifference0.2%
- Check51 days agoChange DetectedAdded new MedlinePlus Genetics topic on Cystic fibrosis; no deletions observed. This expands core content with a relevant genetic topic.SummaryDifference0.3%
Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.